DNQX

DNQX

CAT N°: 14583
Price:

From 55.00 46.75

DNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 ?M for AMPA and kainate receptors, respectively versus IC50 = 40 ?M for NMDA receptors).{23070,23071,23072} This compound has been used to specifically target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors. DNQX does not stimulate a robust long-term potentiation in the hippocampus.{23069}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 1,4-dihydro-6,7-dinitro-2,3-quinoxalinedione
  • Correlated keywords
    • 1312992-24-7 signals transductions DNQX non-NMDA glutamates receptors antagonists AMPA kainates neurosciences quinoxalinediones synaptic transmissions non NMDAs non competitives responses 6,7-dinitroquinoxaline-2,3-dione dinitroquinoxalines diones 6 7 2 3 stimulates robust long-term longs terms potentiations hippocampus
  • Product Overview:
    DNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 ?M for AMPA and kainate receptors, respectively versus IC50 = 40 ?M for NMDA receptors).{23070,23071,23072} This compound has been used to specifically target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors. DNQX does not stimulate a robust long-term potentiation in the hippocampus.{23069}

We also advise you